,,

Itzel Condado-Morales1,2, Fabian Dingfelder1,2, Isabel Waibel2

  • 1Department of Biophysics and Injectable Formulation, Global Research Technologies, Novo Nordisk A/S, Måløv, Denmark.

mAbs
|October 4, 2024
PubMed
概括

工程抗体格式显示出潜力,但面临着可开发性挑战. 全长抗体通常比复杂的工程格式,如双特异和抗体碎片,具有更高的开发能力.